A Mother and Her Teenage Daughter Finally Have Answers—and Relief
No mother wants to watch their child suffer in pain, least of all when she is helpless to alleviate that pain. After watching her 16-year-old daughter suffer with debilitating pain for nearly a year, one mother in the United Kingdom was desperate for answers. The doctors she had seen didn’t fully comprehend what was causing her mysterious “ailment”. None of the treatments they prescribed her daughter were effective; the pain simply persisted. That is when she happened to contact Dr. David Griffiths, an endometriosis specialist in the UK who was in the recently media discussing the EndoSure test.
The mother shared:
“For nearly a year, my daughter suffered from excessive pain and heavy bleeding. Our general practitioner tried many options, but none worked. After an abdominal scan showed no root cause, out of sheer desperation, I contacted Mr. Griffiths’ clinic [doctors in the UK are called misters]. That changed everything.
After undergoing the EndoSure test, Within an hour we had a plan to address the root cause of her unrelenting pain. Mr. Griffin effectively managed my daughter’s symptoms so she could get through her academic exams, and partake in normal activities for 16-year-old adolescents.
The 30-minute endo test was amazing and best of all, non-invasive. It confirmed my daughter has endometriosis, something we likely wouldn’t have known for years without it. The medication prescribed to her has been life changing.”
Her daughter, too, was grateful that her pain was no longer being dismissed:
“After feeling unheard by my doctors and being wrongly told my extreme pain was due to fibroids, and I needed surgery, I went to see Mr. Griffiths. He told me about the painless EndoSure test. It was a non-invasive procedure that took less than an hour. It confirmed I have severe endometriosis.
"It feels so good to at last be listened to, and taken seriously. Finally, I have a treatment plan that works. Thank you so much!”
Disruptive tools like the
EndoSure test are empowering doctors every day to intervene earlier, shortening the usual 8.6 years from onset of symptoms to diagnosis to only 30 minutes.
With the EndoSure Test, all health care providers, regardless of their familiarity or depth of knowledge of disease can easily confirm or exclude the presence of endometriosis in patients of any age, at any disease stage, anywhere in the anatomy,.
Equally important, the endo test enables them to implement a personalized treatment plan with confidence, knowing the patient has a greater likelihood to respond to treatment, ending years of suffering and improving the quality of life for millions of women around the world.
UK Teen Plays Sports Again, Pain-Free, After Endometriosis Diagnosis
A 16-year-old young woman in the United Kingdom had been suffering from increasing pain and heavy bleeding during, and sometimes between her periods. Previous treatments were ineffective, causing her to miss school and activities because her pain was so severe.
Because her mother had been diagnosed with endometriosis (suggesting a family history of this condition), they sought out an endometriosis specialist, who recommended the EndoSure test.
Here’s what the young woman had to say:
“The gynecologist gave me some options, including laparoscopic surgery, but he didn’t advise it because I’m only 16-years-old. He also gave me the option of taking the 30-minute, painless endo test. Because it was noninvasive, my mom and I were eager to try it, and I’m so glad I did.
The test confirmed I have endometriosis.
I’m grateful that I found out early because it means that now I am in control of my life. I was prescribed a new pill called Ryeqo, which has been life changing. Now, I only have moderate pain when I ovulate-–nothing like it used to be. I can play sports again, and I’m not missing school because of terrible pain and heavy periods.”
The EndoSure test non-invasively detects the presence of endometriosis in patients of any age, at any disease stage, anywhere in the anatomy. Thanks to a positive EndoSure test result, this young woman’s doctor was able to prescribe a targeted treatment to which she positively responded, ending a long uncertain journey of ineffective treatments. Moreover, after treatment the TEST can be used to monitor treatment efficacy during routine office visits.
Women who suffer from endometriosis deserve a timely and accurate diagnosis. At ENDOSURE, we are uniquely positioned to help all clinicians make significant progress in the diagnosis for the millions of women with this condition. More and more caregivers are recognizing the positive disruptive ability of the Endosure test as the first test to break the cycle of missed diagnosis.
Women who suffer from endometriosis deserve a timely and accurate diagnosis. At ENDOSURE, we are uniquely positioned to help all clinicians make significant progress in the diagnosis for the millions of women with this condition. More and more caregivers are recognizing the positive disruptive ability of the EndoSure test as the first test to break the cycle of missed diagnosis.
ABOUT US
ENDOSURE, INC. offers the only non-invasive, 30-minute, highly accurate diagnosis test for endometriosis that not only fills the gap, but addresses the vacuum in this area of women’s health care.*
© February 2025 ENDOSURE, INC. All rights reserved
site design by
Boston Web Partners
CONTACT INFORMATION
1. Approximately 15-20 minutes of patient preparation time may be required prior to performing the test.
2. Mathias JR, Franklin R, Quast DC, Fraga N, Loftin CA, Yates L, Harrison V. Relation of endometriosis and neuromuscular disease of the gastrointestinal tract: new insights. Fertil Steril. 1998 Jul;70(1):81-8.
3. i. Noar M, Mathias J, Kolatkar A. Gastrointestinal Myoelectrical Activity (GIMA) Biomarker for Noninvasive Diagnosis of Endometriosis. J Clin Med. 2024 May 13;13(10):2866. doi: 10.3390/jcm13102866. PMID: 38792407; PMCID: PMC11122642.
4. Zondervan, K.T.; Becker, C.M.; Koga, K.; Missmer, S.A.; Taylor, R.N.; Viganò, P. Endometriosis. Nat. Rev. Dis. Primers. 2018:4-9.
5. 1. Noar M, Mathias J, Kolatkar A. Validation of New GIMA Biomarker Signature of Endometriosis - Interim Data: Research Article. TechRxiv. August 26, 2024. DOI: 10.22541/au.172469630.08159498/v1
6. 1. Kitsantas P, Benson KN, Al-Farauki S, Knecht MK, Hennekens CH, et al. (2024) Emerging Diagnostic Tools for the Early Diagnosis of Endometriosis. J Reprod Med Gynecol Obstet 9: 171.
DISCLAIMER: THE ENDOSURE TEST IS A DIAGNOSTIC TOOL INTENDED TO INFORM AND ENHANCE A HEALTHCARE PROVIDER'S DECISION-MAKING PROCESS, WHICH IS INDIVIDUALIZED FOR EACH PATIENT'S CIRCUMSTANCES AND TAKE INTO ACCOUNT THE FULL SCOPE OF MEDICAL DATA AND INFORMATION AVAILABLE TO THE PROVIDER. THE ENDOSURE TEST IS NOT INTENDED TO SUBSTITUTE, REPLACE, OVERRULE, OR DIRECT A HEALTHCARE PROVIDER’S JUDGMENT.
443-391-7500
* USA CUSTOMERS: EndoSure is currently available for research in the USA use only and not clinical use.